Medscape3m
GLP-1 Prescribing Decisions: Compounded or Brand-Name?
With brand-name GLP-1s for obesity treatment on and off the shortage list, prescribing can get complicated. Five providers ...
Last year, 7.5% of our population was treated for diabetes...48% of simultaneous treatment of hypertension
While the number of diabetic patients in Korea is steadily increasing due to the aging population, the number of patients ...
The Financial Express29m
Lancet study finds one-fourth of global diabetes cases in India; Doctor urges lifestyle changes to curb rise
World Diabetes Day 2024: An alarming study published in the Lancet journal has revealed that one-fourth of adults living with ...
The Citizen30m
Health centre celebrates World Diabetes Day
The community of Mamelodi were informed that knowing the early signs is key in helping individuals recognise and seek help ...
Lilly reports trial results of tirzepatide for treating obesity and pre-diabetes
Spanning 176 weeks of treatment, the Phase III trial evaluated the efficacy and safety of tirzepatide in adults without type ...
Women and Diabetes: Unique challenges, risks, and management
Diabetes affects women differently than men. Women with diabetes have a higher risk of heart disease and other complications ...
Deccan Chronicle59m
More than 21 crore Indians living with diabetes: Lancet study
About 82.8 crore people around the world are estimated to be living with diabetes in 2022, with over a quarter in India, ...
Mid-Day on MSN59m
The link between sleep disorders and diabetes management
According to the World Health Organization estimates, about 422 million people worldwide have diabetes, and 1.5 million deaths are directly attributed to diabetes each year. Even though diabetes can ...